Key | % Net Assets |
---|---|
![]() |
3.9% |
![]() |
3.8% |
![]() |
3.2% |
![]() |
3.0% |
![]() |
86.1% |
Name | % Net Assets |
---|---|
BP | 3.9% |
Royal Dutch Shell | 3.8% |
HSBC Hldgs | 3.2% |
GlaxoSmithKline | 3.0% |
Treasury 4.25% 12/2055 | 2.6% |
GlaxoSmithKline | 2.5% |
DBR 4.25 07/39 | 2.4% |
BG Group | 1.7% |
BHP Billiton | 1.4% |
AstraZeneca | 1.3% |
No asset data available.
Date | 25-Apr-2025 |
---|---|
NAV | 50.15p |
Currency | GBP |
Change | 0.14p |
% | 0.28% |
YTD change | 0.70p |
YTD % | 1.42% |
Fund Inception | 06/04/2005 |
---|---|
Fund Manager | Matthew Merritt |
TER | - |
Minimum Investment | |
---|---|
Initial | £3000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.07 |
You are here: research